Search clinical trials for: Active comparator: European Union licenced epoetin alfa

Total 79 results

Megalabs
Azidus Laboratories

Not yet recruiting

Comparative Study of Two Recombinant Human Erythropoietin Products on Chronic Kidney Disease Patients (ENCASE)

Anemia of Chronic Kidney Disease

Uruguay
Sandoz

Completed

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa (ACCESS)

Anemia | Chronic Kidney Disease (CKD)

United States
NICHD Neonatal Research Network
National Center for Research Resources (NCRR)

Completed

The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants (EPO)

Anemia, Neonatal | Infant, Small for Gestational Age | Infant, Premature | Infant, Low Birth Weight | Infant, Newborn

United States
mAbxience Research S.L.

Completed

A Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers

Healthy Volunteers

United Kingdom
AGO Study Group

Terminated

Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum

Anemia | Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum | Platinum Sensitve Relapse

Germany
The Center for Clinical and Cosmetic Research
BirchBioMed Inc.

Completed

"A Clinical Study Investigating the Effectiveness of OTC Scar-management Modalities"

Cicatrix | Scar | Keloid | Hypertrophic Scar

United States
Megalabs

Not yet recruiting

Biosimilarity Study of Subcutaneous Recombinant Human Erythropoietin in Healthy Volunteers

Healthy
Sheba Medical Center

Withdrawn

The Effect of Algae Dunaliella Bardawil on Psoriasis (2)

Psoriasis

Israel
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Lung Cancer

United States
GlaxoSmithKline
PPD

Completed

Dose Ranging of GSK2336805 in Combination Therapy (HAI115879)

Hepatitis C, Chronic

Puerto Rico, United States, Bulgaria, Germany, Belgium, France
Groupe Francophone des Myelodysplasies
Roche Pharma AG; Celgene Corporation

Completed

Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)

Myelodysplastic Syndromes

France
Virginia Commonwealth University
Ortho Biotech, Inc.

Completed

Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection

Hepatitis C

United States
Amgen

Completed

A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related Complex

HIV Infections | Cytopenias

United States
Amgen

Completed

An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)

HIV Infections

United States
Merck Sharp & Dohme LLC

Completed

MK0507A Clinical Study in Patients With Glaucoma and Ocular Hypertension (0507A-149)(COMPLETED)

Glaucoma
ModernaTX, Inc.

Completed

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

Seasonal Influenza

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Pancreatic Cancer

United States
Merck Sharp & Dohme LLC

Withdrawn

Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

Chronic Genotype 1 Hepatitis C Virus Infection
PETHEMA Foundation
Roche Pharma AG; Celgene Corporation

Terminated

SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome (SIMIDIS)

Myelodysplastic Syndrome

Spain
Nordic MDS Group

Completed

Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome

Denmark, Norway, Sweden
Hospital Carlos III, Madrid

Unknown

Phase IV Study to Evaluate the Efficacy/Safety to Extend Treatment and High Dose of Ribavirin in co-Infected Patients (PERICO)

Chronic Hepatitis C

Spain
Larry Cripe, MD
Celgene Corporation; Ortho Biotech Clinical Affairs, L.L.C.; Walther Cancer Institute

Terminated

Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Novartis Pharmaceuticals

Terminated

LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS) (GEPARD)

Myelodysplastic Syndrome (MDS)

Germany
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Viral Kinetics of Treatment With Peginterferon Alpha-2a, Ribavirin and Epoetin β in Patients Coinfected HCV/HIV

HIV Infections

Spain
Bundang CHA Hospital
Korea Evaluation Institute of Industrial Technology

Unknown

Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients

Stroke | Safety | Treatment Outcome | Erythropoietin | Umbilical Cord Blood

Korea, Republic of
Hoffmann-La Roche

Completed

A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.

Anemia

France
ARCAGY/ GINECO GROUP
GlaxoSmithKline

Recruiting

Endometrial Cancer Patientes MMR Deficient Comparing Chemotherapy vs Dostarlimab in First Line (DOMENICA)

Endometrial Cancer

France, Spain, Singapore, Australia, Canada
Takeda

Completed

Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux Disease

Gastroesophageal Reflux

United States
Dr. Conrado Fernandez

Completed

High Dose Versus Standard Dose of Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (DARGEN-3)

Chronic Hepatitis C

Spain
Organon and Co

Completed

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)

Acute Migraine
Takeda

Completed

Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease

Gastroesophageal Reflux Disease

United States
Merck Sharp & Dohme LLC

Completed

Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)

Hepatitis C, Chronic
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Peginterferon Alfa-2a, Ribavirin and Epoetin β in Coinfected Patients HCV/HIV Not Responding to Previous Treatment Regimens

HIV Infections | Hepatitis C

Spain
Region Skane

Completed

Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery (EPRICS)

Renal Failure | Kidney Failure

Sweden
United States Army Research Institute of Environmental...
University of Puget Sound

Recruiting

Pharmacological Countermeasures for High Altitude

Hypobaric Hypoxia

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia

Chronic Kidney Disease | Sickle Cell Disease | Pulmonary Hypertension

United States
Novartis Pharmaceuticals

Completed

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

Low and Int 1-risk Myelodysplastic Syndrome

Germany, Canada, Korea, Republic of, Sweden, Spain, China, Argentina, Italy, United Kingdom, Algeria
Akebia Therapeutics

Completed

Study of Vadadustat in Hemodialysis Participants With Anemia Switching From Epoetin Alfa (FO2RWARD-2)

Anemia | Dialysis-dependent Chronic Kidney Disease

United States
Julia Xu
Carnegie Mellon University; American Society of Hematology

Recruiting

Hydroxyurea and EPO in Sickle Cell Disease (ACHiEvE-SCD)

Sickle Cell Disease | Anemia, Sickle Cell

United States, Nigeria
Second Affiliated Hospital, School of Medicine,...

Recruiting

Effect of the Combined Programme on Perioperative Anaemia（CPPA）

Cardiac Surgery | Iron Deficiency Anemia | Patient Blood Management

China
Hanna Jangö
Region Hovedstadens Apotek

Recruiting

Oral Antibiotics After Obstetric Perineal Tear (REPAIR)

Infections | Wound Dehiscence | Obstetric Trauma

Denmark
Stanford University

Completed

Triclosan, Triclocarban, and the Microbiota

Triclosan Effects on Microbial Flora

United States
NCIC Clinical Trials Group
Southwest Oncology Group; Cancer and Leukemia Group B; North Central Cancer Treatment...

Completed

Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer

Breast Cancer

Canada, United States
University Hospital, Montpellier

Completed

Cross Iron (Comparative Randomized Oral Versus Systemic IRON) (Cross Iron)

Knee Arthroplasty | Hip Arthroplasty | Allogenic Transfusion | Perioperative Anaemia

France
Corporal Michael J. Crescenz VA Medical Center

Withdrawn

Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function (ISMN)

Hypertension

United States
University of Roma La Sapienza

Completed

Administration of Human Protein C Concentrates in Patients With Sepsis and Septic Shock.

Sepsis | Septic Shock

Italy
Fresenius Medical Care North America

Terminated

A Safety Study of Pentoxifylline for the Treatment of Anemia

End Stage Renal Disease

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)

Type 2 Diabetes Mellitus
Eunice Kennedy Shriver National Institute of Child...

Unknown

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

Cancer

United States
Ahn-Gook Pharmaceuticals Co.,Ltd

Unknown

Investigate a Interaction of Candesartan and Atorvastatin in Healthy Male Sugjects

Healthy Male Subjects

Korea, Republic of

3

Subscribe